Acebutolol

Active ingredient description

Acebutolol is a beta adrenoceptor antagonist which is cardioselective, i.e. acts preferentially on beta-1 adrenergic receptors in the heart. Its principal effects are to reduce heart rate especially on exercise and to lower blood pressure in hypertensive subjects.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Acebutolol
C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB04

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₁₈H₂₈N₂O₄
Molecular mass: 336.426 g/mol

External identifiers

CAS Substance: 37517-30-9
DrugBank Drug: DB01193
KEGG Drug: D02338
PubChem Compound: 1978
RxNorm Ingredient: 149
SNOMED-CT Concept: 372815001
Acebutolol (substance)
UNII Identifier: 67P356D8GH
ACEBUTOLOL

Medicines

Acebutolol is an active ingredient of these brands:

Finland (FI)

France (FR)

  • SECTRAL as ACEBUTOLOL HYDROCHLORIDE

Japan (JP)

Poland (PL)

  • ACECOR as ACEBUTOLOL HYDROCHLORIDE

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

  • SECTRAL as ACEBUTOLOL HYDROCHLORIDE

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.